Anna Kagramanova

P005 Influence of Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases on the Level of Immunoglobulins G After a Coronavirus Infection

BACKGROUND: Currently, there are differences in the results of international studies and treatment outcomes in patients with inflammatory bowel disease (IBD) and COVID-19. Fur...

Marina Chernova ;

Anna Kagramanova ;

Anait Babayan ;

Alexandra Demchenko ;

Albina Lishchinskaya ;

Asfold Parfenov ;

Oleg Knyazev ;

12/15/2021

P007 The Frequency of Anxiety and Depression in Patients With Inflammatory Bowel Diseases in the Moscow Clinical Scientific Center

BACKGROUND: Anxiety and depression occur in a significant number of patients with inflammatory bowel diseases (IBD). The prevalence of anxiety and / or depression is 13-44.4% ...

Mariya Zvyaglova ;

Oleg Knyazev ;

Irina Li ;

Natalya Bodunova ;

Lyudmila Firsova ;

Anna Kagramanova ;

Valeriy Ogarev ;

Albina Lishchinskaya ;

Asfold Parfenov ;

12/15/2021

P004 Steroid-Free Remission in Patients With Ulcerative Colitis Receiving Tofacitinib in Real Clinical Practice

BACKGROUND: Tofacitinib is a selective immunosuppressant, the first representative of the inhibitors of the janus kinase family, which has high selectivity against other kinas...

Irina Li ;

Anna Kagramanova ;

Tatyana Shkurko ;

Albina Lishchinskaya ;

Anait Babayan ;

Oleg Knyazev ;

Dmitriy Kulakov ;

12/15/2021

P006 The Relationship of Histological Remission With the Duration of the Anamnesis Ulcerative Colitis

BACKGROUND: The objectives of the treatment of patients with ulcerative colitis (UC) in accordance with the STRIDE-I provision, involves endoscopic healing of the colon mucosa...

Oleg Knyazev ;

Karina Noscova ;

Sergey Khomeriki ;

Irina Li ;

Tatyana Shkurko ;

Anna Kagramanova ;

Albina Lishchinskaya ;

Asfold Parfenov ;

12/15/2021

Mesenchymal Stromal Cells of Bone Marrow Reduce the Risk of Postoperative Recurrence of Crohn`s Disease

BACKGROUND: Crohn's disease (CD) in the form of terminal ileitis occurs in approximately 1/3 of CD patients and is often complicated by the formation of ileum stricture or ileocecal ...

Anait Babayan ;

Oleg Knyazev ;

Dmitriy Kulakov ;

Anna Kagramanova ;

Anatoliy Konoplyannikov ;

Asfold Parfenov ;

Mariya Zvyaglova ;

korneeva Irina ;

12/12/2019

Combined therapy with adalimumab and mesenchymal stromal cells contributes to reduction in the degree of inflammation in ulcerative colitis

BACKGROUND: One of the new promising methods of treatment of patients with ulcerative colitis (UC) is biological therapy using bone marrow mesenchymal stromal cells (MCS).

Marina Chernova ;

Oleg Knyazev ;

Sergey Khomeriki ;

Dmitriy Kulakov ;

Anna Kagramanova ;

Anatoliy Konoplyannikov ;

Albina Lishchinskaya ;

Asfold Parfenov ;

Mariya Zvyaglova ;

11/20/2018

Comparative frequency of Clostridial infection in patients with ulcerative colitis receiving mesenchymal stromal cells and biological preparations

BACKGROUND: Patients with inflammatory bowel disease (IBD) experienced more frequent development of Clostridial infection and much higher rates of morbidity and mortality compared to pati...

Anna Kagramanova ;

Albina Lishchinskaya ;

Asfold Parfenov ;

Marina Chernova ;

Oleg Knyazev ;

11/20/2018